Ambrisentan - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509245017

Publication Date:

September 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Ambrisentan was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Ambrisentan is used to treat symptoms of pulmonary arterial hypertension, which is high blood pressure in the main artery that carries blood from the right side of the heart (the ventricle) to the lungs, to improve your ability to exercise and slow down the worsening of your condition.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ambrisentan, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ambrisentan by region & country, by Type, and by Application.
The Ambrisentan market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ambrisentan.
麻豆原创 Segmentation
By Company
Megafine
Yichang Tianren Pharmaceutical
Confucius Pharmceutical
Gilead Sciences
Cipla
MSN Laboratories
Segment by Type:
鈮� 99%
锛� 99%
Segment by Application
Pulmonary Hypertension Phase II
Application 2
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ambrisentan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ambrisentan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ambrisentan in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Ambrisentan Product Introduction
1.2 Global Ambrisentan 麻豆原创 Size Forecast
1.2.1 Global Ambrisentan Sales Value (2019-2030)
1.2.2 Global Ambrisentan Sales Volume (2019-2030)
1.2.3 Global Ambrisentan Sales Price (2019-2030)
1.3 Ambrisentan 麻豆原创 Trends & Drivers
1.3.1 Ambrisentan Industry Trends
1.3.2 Ambrisentan 麻豆原创 Drivers & Opportunity
1.3.3 Ambrisentan 麻豆原创 Challenges
1.3.4 Ambrisentan 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ambrisentan Players Revenue Ranking (2023)
2.2 Global Ambrisentan Revenue by Company (2019-2024)
2.3 Global Ambrisentan Players Sales Volume Ranking (2023)
2.4 Global Ambrisentan Sales Volume by Company Players (2019-2024)
2.5 Global Ambrisentan Average Price by Company (2019-2024)
2.6 Key Manufacturers Ambrisentan Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Ambrisentan Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ambrisentan
2.9 Ambrisentan 麻豆原创 Competitive Analysis
2.9.1 Ambrisentan 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Ambrisentan Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ambrisentan as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 鈮� 99%
3.1.2 锛� 99%
3.2 Global Ambrisentan Sales Value by Type
3.2.1 Global Ambrisentan Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ambrisentan Sales Value, by Type (2019-2030)
3.2.3 Global Ambrisentan Sales Value, by Type (%) (2019-2030)
3.3 Global Ambrisentan Sales Volume by Type
3.3.1 Global Ambrisentan Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Ambrisentan Sales Volume, by Type (2019-2030)
3.3.3 Global Ambrisentan Sales Volume, by Type (%) (2019-2030)
3.4 Global Ambrisentan Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pulmonary Hypertension Phase II
4.1.2 Application 2
4.2 Global Ambrisentan Sales Value by Application
4.2.1 Global Ambrisentan Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ambrisentan Sales Value, by Application (2019-2030)
4.2.3 Global Ambrisentan Sales Value, by Application (%) (2019-2030)
4.3 Global Ambrisentan Sales Volume by Application
4.3.1 Global Ambrisentan Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Ambrisentan Sales Volume, by Application (2019-2030)
4.3.3 Global Ambrisentan Sales Volume, by Application (%) (2019-2030)
4.4 Global Ambrisentan Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Ambrisentan Sales Value by Region
5.1.1 Global Ambrisentan Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ambrisentan Sales Value by Region (2019-2024)
5.1.3 Global Ambrisentan Sales Value by Region (2025-2030)
5.1.4 Global Ambrisentan Sales Value by Region (%), (2019-2030)
5.2 Global Ambrisentan Sales Volume by Region
5.2.1 Global Ambrisentan Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Ambrisentan Sales Volume by Region (2019-2024)
5.2.3 Global Ambrisentan Sales Volume by Region (2025-2030)
5.2.4 Global Ambrisentan Sales Volume by Region (%), (2019-2030)
5.3 Global Ambrisentan Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Ambrisentan Sales Value, 2019-2030
5.4.2 North America Ambrisentan Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Ambrisentan Sales Value, 2019-2030
5.5.2 Europe Ambrisentan Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Ambrisentan Sales Value, 2019-2030
5.6.2 Asia Pacific Ambrisentan Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Ambrisentan Sales Value, 2019-2030
5.7.2 South America Ambrisentan Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ambrisentan Sales Value, 2019-2030
5.8.2 Middle East & Africa Ambrisentan Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ambrisentan Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ambrisentan Sales Value
6.2.1 Key Countries/Regions Ambrisentan Sales Value, 2019-2030
6.2.2 Key Countries/Regions Ambrisentan Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Ambrisentan Sales Value, 2019-2030
6.3.2 United States Ambrisentan Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ambrisentan Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ambrisentan Sales Value, 2019-2030
6.4.2 Europe Ambrisentan Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ambrisentan Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ambrisentan Sales Value, 2019-2030
6.5.2 China Ambrisentan Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ambrisentan Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ambrisentan Sales Value, 2019-2030
6.6.2 Japan Ambrisentan Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ambrisentan Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ambrisentan Sales Value, 2019-2030
6.7.2 South Korea Ambrisentan Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ambrisentan Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ambrisentan Sales Value, 2019-2030
6.8.2 Southeast Asia Ambrisentan Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ambrisentan Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ambrisentan Sales Value, 2019-2030
6.9.2 India Ambrisentan Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ambrisentan Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Megafine
7.1.1 Megafine Company Information
7.1.2 Megafine Introduction and Business Overview
7.1.3 Megafine Ambrisentan Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Megafine Ambrisentan Product Offerings
7.1.5 Megafine Recent Development
7.2 Yichang Tianren Pharmaceutical
7.2.1 Yichang Tianren Pharmaceutical Company Information
7.2.2 Yichang Tianren Pharmaceutical Introduction and Business Overview
7.2.3 Yichang Tianren Pharmaceutical Ambrisentan Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Yichang Tianren Pharmaceutical Ambrisentan Product Offerings
7.2.5 Yichang Tianren Pharmaceutical Recent Development
7.3 Confucius Pharmceutical
7.3.1 Confucius Pharmceutical Company Information
7.3.2 Confucius Pharmceutical Introduction and Business Overview
7.3.3 Confucius Pharmceutical Ambrisentan Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Confucius Pharmceutical Ambrisentan Product Offerings
7.3.5 Confucius Pharmceutical Recent Development
7.4 Gilead Sciences
7.4.1 Gilead Sciences Company Information
7.4.2 Gilead Sciences Introduction and Business Overview
7.4.3 Gilead Sciences Ambrisentan Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Gilead Sciences Ambrisentan Product Offerings
7.4.5 Gilead Sciences Recent Development
7.5 Cipla
7.5.1 Cipla Company Information
7.5.2 Cipla Introduction and Business Overview
7.5.3 Cipla Ambrisentan Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Cipla Ambrisentan Product Offerings
7.5.5 Cipla Recent Development
7.6 MSN Laboratories
7.6.1 MSN Laboratories Company Information
7.6.2 MSN Laboratories Introduction and Business Overview
7.6.3 MSN Laboratories Ambrisentan Sales, Revenue and Gross Margin (2019-2024)
7.6.4 MSN Laboratories Ambrisentan Product Offerings
7.6.5 MSN Laboratories Recent Development
8 Industry Chain Analysis
8.1 Ambrisentan Industrial Chain
8.2 Ambrisentan Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ambrisentan Sales Model
8.5.2 Sales Channel
8.5.3 Ambrisentan Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Megafine
Yichang Tianren Pharmaceutical
Confucius Pharmceutical
Gilead Sciences
Cipla
MSN Laboratories

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.